Delivery Order SPE2DB24D2100-SPE2DB24FBCDR
Award Date
6/27/24
Potential Completion Date
6/28/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,644.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of the medication NEUPOGEN 300 MCG/ML VIALML, with an ultimate completion date of April 17, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $3,644.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the NEUPOGEN 300 MCG/ML VIALML product, with a firm fixed price and an ultimate completion date of June 11, 2025. AmerisourceBergen Drug Corp, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,654.79 Firm Fixed Price Delivery Order is for the supply of NEUPOGEN 300 MCG/ML, a prescription medication, with a completion date of June 28, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds Indefinite Delivery Contracts (IDCs) with both the DLA, valued up to...
The U.S. Defense Logistics Agency awarded a Firm Fixed Price delivery order contract valued at $2,303.34 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of NEUPOGEN 300 MCG/ML VIALML pharmaceutical products to support federal government medical requirements. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML, a specialty pharmaceutical product. The contract has a firm fixed price of $17,160.11 and a period of performance through November 14, 2024. Amerisourcebergen is a major pharmaceutical distribution and healthcare solutions provider, and this contract is part of the company's broader Indefinite Delivery Contract (IDC) with the DLA...
This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. Under this contract, Amerisourcebergen will deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, involves the delivery of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and other government agencies. The contract, valued at up to $4,392.66, is a Delivery Order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC, worth up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products and medical supplies to the Department of Defense (DoD) and its medical treatment facilities worldwide. The contract, valued up to $999,999,999.00, is an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products and medical supplies to the U.S. government. The $1,878.35 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025, to...